1. Home
  2. RGC vs PFO Comparison

RGC vs PFO Comparison

Compare RGC & PFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGC
  • PFO
  • Stock Information
  • Founded
  • RGC 2014
  • PFO 1991
  • Country
  • RGC Hong Kong
  • PFO United States
  • Employees
  • RGC N/A
  • PFO N/A
  • Industry
  • RGC Medicinal Chemicals and Botanical Products
  • PFO Finance Companies
  • Sector
  • RGC Health Care
  • PFO Finance
  • Exchange
  • RGC Nasdaq
  • PFO Nasdaq
  • Market Cap
  • RGC 105.3M
  • PFO 123.7M
  • IPO Year
  • RGC 2021
  • PFO N/A
  • Fundamental
  • Price
  • RGC $4.87
  • PFO $9.09
  • Analyst Decision
  • RGC
  • PFO
  • Analyst Count
  • RGC 0
  • PFO 0
  • Target Price
  • RGC N/A
  • PFO N/A
  • AVG Volume (30 Days)
  • RGC 51.3K
  • PFO 31.8K
  • Earning Date
  • RGC 12-20-2024
  • PFO 01-01-0001
  • Dividend Yield
  • RGC N/A
  • PFO 6.51%
  • EPS Growth
  • RGC N/A
  • PFO N/A
  • EPS
  • RGC N/A
  • PFO N/A
  • Revenue
  • RGC N/A
  • PFO N/A
  • Revenue This Year
  • RGC N/A
  • PFO N/A
  • Revenue Next Year
  • RGC N/A
  • PFO N/A
  • P/E Ratio
  • RGC N/A
  • PFO N/A
  • Revenue Growth
  • RGC N/A
  • PFO N/A
  • 52 Week Low
  • RGC $3.03
  • PFO $6.90
  • 52 Week High
  • RGC $32.44
  • PFO $8.51
  • Technical
  • Relative Strength Index (RSI)
  • RGC 36.17
  • PFO 39.28
  • Support Level
  • RGC $5.41
  • PFO $9.15
  • Resistance Level
  • RGC $6.10
  • PFO $9.28
  • Average True Range (ATR)
  • RGC 0.42
  • PFO 0.09
  • MACD
  • RGC -0.10
  • PFO -0.00
  • Stochastic Oscillator
  • RGC 1.14
  • PFO 26.67

About RGC Regencell Bioscience Holdings Limited

Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.

About PFO Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated

Flaherty & Crumrine Prfd Income Oppo is the United States-based diversified, closed-end investment company. Its primary investment objective is to produce high current income consistent with the preservation of capital. The fund invests in a diversified portfolio of preferred securities which includes traditional preferred stocks eligible for the inter-corporate dividends received a deduction and fully taxable preferred securities.

Share on Social Networks: